Even the most promising vaccines don’t always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development. We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies.
The Netherlands-based Intravacc, part of the Utrecht Science Park location Bilthoven, is one of the world’s leading organizations with many years of experience in translational vaccinology. As an established independent clinical development and manufacturing organization (CDMO) in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials in humans.
Intravacc performs her activities in compliance with applicable laws and regulations.
The care for employees and for the environment is a top priority for Intravacc. Sustainability is important to guarantee a safe and health environment for the future. Therefore, Intravacc implemented an environmental management system according to ISO 14001.
An external company regularly audits the management systems for ISO 14001 to assure continuously compliance.
For the manufacturing and quality control of clinical trial materials, Intravacc B.V. has a manufacturing license granted by the Dutch Authorities. Regular inspections are performed by the Dutch Inspectorate of Health to verify compliance.
Are you interested in becoming part of an innovative community, to learn alongside top scientists, to work with state-of-the art equipment, to get an inside look of and contribute to the biotech sector, where industry leaders, government, universities and international non-governmental organizations collaborate? Then Intravacc is the place for you.
Stay up to date with the latest developments, and be the first to receive our news updates and announcements.
